PRMT5 Associates With the FOXP3 Homomer and When Disabled Enhances Targeted p185erbB2/neu Tumor ImmunotherapyYasuhiro Nagai, Mark I. Greene, Fuxiang Zhu et al.|Frontiers in Immunology|2019Cited by 73